What laboratory studies and diagnostic tests are indicated for a patient with a ten‑year‑old untreated iatrogenic thoracic duct injury that has leaked into the anterior mediastinum forming a chylous cyst following an anterior cervical discectomy and fusion (ACDF) at C5‑C6?

Laboratory and Imaging Workup for Chronic Iatrogenic Thoracic Duct Injury with Mediastinal Chylous Cyst

For a 10-year-old untreated iatrogenic thoracic duct injury with mediastinal chylous cyst formation after ACDF C5-C6, you should obtain MR lymphangiography of the chest and abdomen as your primary diagnostic imaging, supplemented by CT chest with IV contrast to define the cyst anatomy and rule out complications, along with fluid analysis if aspiration is performed (triglycerides >110 mg/dL, fluid-to-serum triglyceride ratio >1.0, and presence of chylomicrons). 1

Primary Diagnostic Imaging

MR Lymphangiography (First-Line)

The 2025 ACR Appropriateness Criteria designate MR lymphangiography as "usually appropriate" for all etiologies of chylous collections, including iatrogenic cases 1. This modality has advanced significantly and provides:

• Dynamic contrast-enhanced MR lymphangiography (DCMRL) with intranodal gadolinium injection offers 3-D volumetric lymphatic flow data that identifies the exact location of the leak and any anatomic variants 1
• Superior visualization of the thoracic duct, cisterna chyli, and tributary vessels compared to CT
• Critical information about lymphatic flow abnormalities that may have developed over 10 years
• Non-invasive assessment before planning any intervention

Clinical Pearl: Given the 10-year chronicity, anatomic variants like transverse branches of the thoracic duct (present in 48% of patients) may be involved, particularly since your injury occurred at C5-C6 where these branches cross the mediastinum 2. MR lymphangiography excels at identifying these variants that conventional imaging misses.

CT Chest with IV Contrast (Complementary)

While CT is inferior to MRI for visualizing lymphatics, it serves essential complementary roles 1:

• Defines the exact size, location, and characteristics of the mediastinal chylous cyst
• Identifies any mass effect on adjacent structures (trachea, esophagus, great vessels)
• Rules out complications like infection, hemorrhage, or compression syndromes
• Provides anatomic roadmap if intervention is needed
• Can visualize the thoracic duct in nearly 100% of cases with 1mm collimation and multiplanar reformation 1

Extend imaging to chest/abdomen/pelvis with IV contrast to fully evaluate the lymphatic system and rule out distal pathology 1.

Laboratory Studies

If Cyst Aspiration is Performed

Confirm chylous nature of the fluid 1:

• Triglyceride level >110 mg/dL (hallmark finding)
• Fluid-to-serum triglyceride ratio >1.0
• Fluid-to-serum cholesterol ratio <1.0 (distinguishes from cholesterol effusions)
• Presence of chylomicrons (definitive)
• Fluid appearance: typically milky, odorless, alkaline, sterile (though appearance varies with nutritional status)

Baseline Metabolic Assessment

Given the chronic nature and potential for ongoing leak 1:

• Serum albumin (assess for protein depletion from chronic leak)
• Complete metabolic panel (electrolyte abnormalities)
• Lymphocyte count (immunosuppression from lymphocyte loss)
• Nutritional markers (prealbumin, total protein)

Conventional Lymphangiography Consideration

While the 2025 ACR guidelines rate conventional lymphangiography as "usually appropriate" 1, this modality serves dual diagnostic and therapeutic purposes:

• Can visualize the leak site with high accuracy (75% success rate when combined with CT) 1
• The lipiodol itself may have therapeutic embolizing effects 3
• Particularly valuable if MR lymphangiography is unavailable or contraindicated
• Clinical success rates of 82-97% for therapeutic effect in appropriate cases 1

Important caveat: In your case with a 10-year-old injury forming a cyst rather than active high-output leak, the therapeutic benefit may be limited, but diagnostic value remains high.

What NOT to Order

• Ultrasound: Rated "not appropriate" for treatment planning in chylous collections 1
• CT chest without contrast: "Not appropriate" for nontraumatic/chronic etiologies 1
• Nuclear lymphoscintigraphy: Redundant if conventional lymphangiography performed; limited evidence base 1

Critical Anatomic Considerations

Your patient's injury occurred during left-sided ACDF at C5-C6, which places them at risk for 4, 5:

• Injury to the main thoracic duct (typically crosses from right to left at T5-T7 level)
• Injury to transverse branches at the carinal or upper tracheal level (present in 48% of patients) 2
• The 10-year chronicity suggests the leak was either low-grade or intermittent, allowing cyst formation rather than acute chylothorax

The fact that a cyst formed in the anterior mediastinum rather than causing chylothorax suggests the leak may be contained or partially sealed, but chronic lymphatic dysfunction persists.

Sequencing Your Workup

1. Start with MR lymphangiography (chest/abdomen) to map the entire lymphatic system and identify the leak source
2. Obtain CT chest/abdomen/pelvis with IV contrast to characterize the cyst and surrounding anatomy
3. If cyst aspiration is performed (for symptom relief or diagnosis), send fluid for triglycerides, cholesterol, and chylomicron analysis
4. Check baseline labs (albumin, metabolic panel, lymphocyte count) to assess chronic effects
5. Consider conventional lymphangiography if MRI is contraindicated or if therapeutic embolization is planned

Why This Matters for Morbidity and Mortality

Chronic chyle leaks cause 1:

• Metabolic abnormalities from ongoing protein and electrolyte loss
• Immunosuppression from lymphocyte depletion
• Malnutrition from fat and fat-soluble vitamin loss
• Respiratory compromise if the cyst enlarges
• Death if left untreated in high-output scenarios

The 10-year duration makes thorough evaluation critical before any intervention, as the anatomy may be significantly altered and treatment planning must account for chronic changes.